Global and China Biogeneric Drugs Market Insights, Forecast to 2026

Global and China Biogeneric Drugs Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Biogeneric Drugs Product Introduction
1.2 Market Segments
1.3 Key Biogeneric Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Biogeneric Drugs Market Size Growth Rate by Type
1.4.2 Insulins
1.4.3 Growth Hormones
1.4.4 Monoclonal Antibodies
1.4.5 Others
1.5 Market by Application
1.5.1 Global Biogeneric Drugs Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinics
1.5.4 Research Centers
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Biogeneric Drugs Market Size, Estimates and Forecasts
2.1.1 Global Biogeneric Drugs Revenue 2015-2026
2.1.2 Global Biogeneric Drugs Sales 2015-2026
2.2 Global Biogeneric Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Biogeneric Drugs Historical Market Size by Region (2015-2020)
2.3.1 Global Biogeneric Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Biogeneric Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Biogeneric Drugs Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Biogeneric Drugs Sales Forecast by Region (2021-2026)
2.4.2 Global Biogeneric Drugs Revenue Forecast by Region (2021-2026)
3 Global Biogeneric Drugs Competitor Landscape by Players
3.1 Global Top Biogeneric Drugs Sales by Manufacturers
3.1.1 Global Biogeneric Drugs Sales by Manufacturers (2015-2020)
3.1.2 Global Biogeneric Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Global Biogeneric Drugs Manufacturers by Revenue
3.2.1 Global Biogeneric Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Global Biogeneric Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Biogeneric Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Biogeneric Drugs Revenue in 2019
3.2.5 Global Biogeneric Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Biogeneric Drugs Price by Manufacturers
3.4 Global Biogeneric Drugs Manufacturing Base Distribution, Product Types
3.4.1 Biogeneric Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Biogeneric Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Biogeneric Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Biogeneric Drugs Market Size by Type (2015-2020)
4.1.1 Global Biogeneric Drugs Sales by Type (2015-2020)
4.1.2 Global Biogeneric Drugs Revenue by Type (2015-2020)
4.1.3 Biogeneric Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Biogeneric Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Biogeneric Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Biogeneric Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Biogeneric Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Biogeneric Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Biogeneric Drugs Market Size by Application (2015-2020)
5.1.1 Global Biogeneric Drugs Sales by Application (2015-2020)
5.1.2 Global Biogeneric Drugs Revenue by Application (2015-2020)
5.1.3 Biogeneric Drugs Price by Application (2015-2020)
5.2 Biogeneric Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Biogeneric Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Biogeneric Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Biogeneric Drugs Price Forecast by Application (2021-2026)
6 China by Players, Type and Application
6.1 China Biogeneric Drugs Market Size YoY Growth 2015-2026
6.1.1 China Biogeneric Drugs Sales YoY Growth 2015-2026
6.1.2 China Biogeneric Drugs Revenue YoY Growth 2015-2026
6.1.3 China Biogeneric Drugs Market Share in Global Market 2015-2026
6.2 China Biogeneric Drugs Market Size by Players (International and Local Players)
6.2.1 China Top Biogeneric Drugs Players by Sales (2015-2020)
6.2.2 China Top Biogeneric Drugs Players by Revenue (2015-2020)
6.3 China Biogeneric Drugs Historic Market Review by Type (2015-2020)
6.3.1 China Biogeneric Drugs Sales Market Share by Type (2015-2020)
6.3.2 China Biogeneric Drugs Revenue Market Share by Type (2015-2020)
6.3.3 China Biogeneric Drugs Price by Type (2015-2020)
6.4 China Biogeneric Drugs Market Estimates and Forecasts by Type (2021-2026)
6.4.1 China Biogeneric Drugs Sales Forecast by Type (2021-2026)
6.4.2 China Biogeneric Drugs Revenue Forecast by Type (2021-2026)
6.4.3 China Biogeneric Drugs Price Forecast by Type (2021-2026)
6.5 China Biogeneric Drugs Historic Market Review by Application (2015-2020)
6.5.1 China Biogeneric Drugs Sales Market Share by Application (2015-2020)
6.5.2 China Biogeneric Drugs Revenue Market Share by Application (2015-2020)
6.5.3 China Biogeneric Drugs Price by Application (2015-2020)
6.6 China Biogeneric Drugs Market Estimates and Forecasts by Application (2021-2026)
6.6.1 China Biogeneric Drugs Sales Forecast by Application (2021-2026)
6.6.2 China Biogeneric Drugs Revenue Forecast by Application (2021-2026)
6.6.3 China Biogeneric Drugs Price Forecast by Application (2021-2026)
7 North America
7.1 North America Biogeneric Drugs Market Size YoY Growth 2015-2026
7.2 North America Biogeneric Drugs Market Facts & Figures by Country
7.2.1 North America Biogeneric Drugs Sales by Country (2015-2020)
7.2.2 North America Biogeneric Drugs Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Biogeneric Drugs Market Size YoY Growth 2015-2026
8.2 Europe Biogeneric Drugs Market Facts & Figures by Country
8.2.1 Europe Biogeneric Drugs Sales by Country
8.2.2 Europe Biogeneric Drugs Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Biogeneric Drugs Market Size YoY Growth 2015-2026
9.2 Asia Pacific Biogeneric Drugs Market Facts & Figures by Country
9.2.1 Asia Pacific Biogeneric Drugs Sales by Region (2015-2020)
9.2.2 Asia Pacific Biogeneric Drugs Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Biogeneric Drugs Market Size YoY Growth 2015-2026
10.2 Latin America Biogeneric Drugs Market Facts & Figures by Country
10.2.1 Latin America Biogeneric Drugs Sales by Country
10.2.2 Latin America Biogeneric Drugs Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Biogeneric Drugs Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Biogeneric Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Biogeneric Drugs Sales by Country
11.2.2 Middle East and Africa Biogeneric Drugs Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Sandoz International
12.1.1 Sandoz International Corporation Information
12.1.2 Sandoz International Description and Business Overview
12.1.3 Sandoz International Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Sandoz International Biogeneric Drugs Products Offered
12.1.5 Sandoz International Recent Development
12.2 Teva pharmaceutical industries
12.2.1 Teva pharmaceutical industries Corporation Information
12.2.2 Teva pharmaceutical industries Description and Business Overview
12.2.3 Teva pharmaceutical industries Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Teva pharmaceutical industries Biogeneric Drugs Products Offered
12.2.5 Teva pharmaceutical industries Recent Development
12.3 Mylan
12.3.1 Mylan Corporation Information
12.3.2 Mylan Description and Business Overview
12.3.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Mylan Biogeneric Drugs Products Offered
12.3.5 Mylan Recent Development
12.4 3SBio
12.4.1 3SBio Corporation Information
12.4.2 3SBio Description and Business Overview
12.4.3 3SBio Sales, Revenue and Gross Margin (2015-2020)
12.4.4 3SBio Biogeneric Drugs Products Offered
12.4.5 3SBio Recent Development
12.5 Shanghai Fosun Pharmaceutical
12.5.1 Shanghai Fosun Pharmaceutical Corporation Information
12.5.2 Shanghai Fosun Pharmaceutical Description and Business Overview
12.5.3 Shanghai Fosun Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Shanghai Fosun Pharmaceutical Biogeneric Drugs Products Offered
12.5.5 Shanghai Fosun Pharmaceutical Recent Development
12.6 Tonghua Dongbao Pharmaceutical
12.6.1 Tonghua Dongbao Pharmaceutical Corporation Information
12.6.2 Tonghua Dongbao Pharmaceutical Description and Business Overview
12.6.3 Tonghua Dongbao Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Tonghua Dongbao Pharmaceutical Biogeneric Drugs Products Offered
12.6.5 Tonghua Dongbao Pharmaceutical Recent Development
12.7 Biocon
12.7.1 Biocon Corporation Information
12.7.2 Biocon Description and Business Overview
12.7.3 Biocon Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Biocon Biogeneric Drugs Products Offered
12.7.5 Biocon Recent Development
12.8 Reliance life sciences
12.8.1 Reliance life sciences Corporation Information
12.8.2 Reliance life sciences Description and Business Overview
12.8.3 Reliance life sciences Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Reliance life sciences Biogeneric Drugs Products Offered
12.8.5 Reliance life sciences Recent Development
12.9 Probiomed
12.9.1 Probiomed Corporation Information
12.9.2 Probiomed Description and Business Overview
12.9.3 Probiomed Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Probiomed Biogeneric Drugs Products Offered
12.9.5 Probiomed Recent Development
12.10 Biosidus
12.10.1 Biosidus Corporation Information
12.10.2 Biosidus Description and Business Overview
12.10.3 Biosidus Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Biosidus Biogeneric Drugs Products Offered
12.10.5 Biosidus Recent Development
12.11 Sandoz International
12.11.1 Sandoz International Corporation Information
12.11.2 Sandoz International Description and Business Overview
12.11.3 Sandoz International Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Sandoz International Biogeneric Drugs Products Offered
12.11.5 Sandoz International Recent Development
12.12 Celltrion
12.12.1 Celltrion Corporation Information
12.12.2 Celltrion Description and Business Overview
12.12.3 Celltrion Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Celltrion Products Offered
12.12.5 Celltrion Recent Development
12.13 LG life Science
12.13.1 LG life Science Corporation Information
12.13.2 LG life Science Description and Business Overview
12.13.3 LG life Science Sales, Revenue and Gross Margin (2015-2020)
12.13.4 LG life Science Products Offered
12.13.5 LG life Science Recent Development
12.14 Dong-A Pharmaceutical
12.14.1 Dong-A Pharmaceutical Corporation Information
12.14.2 Dong-A Pharmaceutical Description and Business Overview
12.14.3 Dong-A Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Dong-A Pharmaceutical Products Offered
12.14.5 Dong-A Pharmaceutical Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Biogeneric Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Biogeneric Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Biogeneric Drugs Market Segments
Table 2. Ranking of Global Top Biogeneric Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Biogeneric Drugs Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Insulins
Table 5. Major Manufacturers of Growth Hormones
Table 6. Major Manufacturers of Monoclonal Antibodies
Table 7. Major Manufacturers of Others
Table 8. Global Biogeneric Drugs Market Size Growth Rate by Application 2020-2026 (K MT)
Table 9. Global Biogeneric Drugs Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 10. Global Biogeneric Drugs Sales by Regions 2015-2020 (K MT)
Table 11. Global Biogeneric Drugs Sales Market Share by Regions (2015-2020)
Table 12. Global Biogeneric Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Biogeneric Drugs Sales Forecast by Region (2021-2026) (K MT)
Table 14. Global Biogeneric Drugs Sales by Manufacturers (2015-2020) (K MT)
Table 15. Global Biogeneric Drugs Sales Share by Manufacturers (2015-2020)
Table 16. Global Biogeneric Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Biogeneric Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biogeneric Drugs as of 2019)
Table 18. Biogeneric Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Biogeneric Drugs Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Biogeneric Drugs Price (2015-2020) (USD/MT)
Table 21. Biogeneric Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Biogeneric Drugs Product Type
Table 23. Date of International Manufacturers Enter into Biogeneric Drugs Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Biogeneric Drugs Sales by Type (2015-2020) (K MT)
Table 26. Global Biogeneric Drugs Sales Share by Type (2015-2020)
Table 27. Global Biogeneric Drugs Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Biogeneric Drugs Revenue Share by Type (2015-2020)
Table 29. Biogeneric Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 30. Global Biogeneric Drugs Sales Share by Type (2021-2026)
Table 31. Global Biogeneric Drugs Sales by Application (2015-2020) (K MT)
Table 32. Global Biogeneric Drugs Sales Share by Application (2015-2020)
Table 33. Global Biogeneric Drugs Sales Share by Application (2021-2026)
Table 34. Global Biogeneric Drugs Sales Market Share Forecast by Application (2021-2026)
Table 35. Global Biogeneric Drugs Revenue by Application (2015-2020) (US$ Million)
Table 36. Global Biogeneric Drugs Revenue Market Share Forecast by Application (2021-2026)
Table 37. China Biogeneric Drugs Sales (K MT) of Key Companies (2015-2020)
Table 38. China Biogeneric Drugs Sales Share by Company (2015-2020)
Table 39. China Biogeneric Drugs Revenue (US$ Million) by Company (2015-2020)
Table 40. China Biogeneric Drugs Sales (K MT) by Type (2015-2020)
Table 41. China Biogeneric Drugs Sales Share by Type (2015-2020)
Table 42. China Biogeneric Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 43. China Biogeneric Drugs Price (K MT) by Type (2015-2020)
Table 44. China Biogeneric Drugs Sales (K MT) by Type (2021-2026)
Table 45. China Biogeneric Drugs Sales Share by Type (2021-2026)
Table 46. China Biogeneric Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 47. China Biogeneric Drugs Revenue Share by Type (2021-2026)
Table 48. China Biogeneric Drugs Price (K MT) by Type (2021-2026)
Table 49. China Biogeneric Drugs Sales (K MT) by Application (2015-2020)
Table 50. China Biogeneric Drugs Sales Share by Application (2015-2020)
Table 51. China Biogeneric Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 52. China Biogeneric Drugs Sales (K MT) by Application (2021-2026)
Table 53. China Biogeneric Drugs Sales Share by Application (2021-2026)
Table 54. China Biogeneric Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 55. China Biogeneric Drugs Revenue Share by Application (2021-2026)
Table 56. North America Biogeneric Drugs Sales by Country (2015-2020) (K MT)
Table 57. North America Biogeneric Drugs Sales Market Share by Country (2015-2020)
Table 58. North America Biogeneric Drugs Revenue by Country (2015-2020) (US$ Million)
Table 59. North America Biogeneric Drugs Revenue Market Share by Country (2015-2020)
Table 60. Europe Biogeneric Drugs Sales by Country (2015-2020) (K MT)
Table 61. Europe Biogeneric Drugs Sales Market Share by Country (2015-2020)
Table 62. Europe Biogeneric Drugs Revenue by Country (2015-2020) (US$ Million)
Table 63. Europe Biogeneric Drugs Revenue Market Share by Country (2015-2020)
Table 64. Asia Pacific Biogeneric Drugs Sales by Region (2015-2020) (K MT)
Table 65. Asia Pacific Biogeneric Drugs Sales Market Share by Region (2015-2020)
Table 66. Asia Pacific Biogeneric Drugs Revenue by Region (2015-2020) (US$ Million)
Table 67. Asia Pacific Biogeneric Drugs Revenue Market Share by Region (2015-2020)
Table 68. Latin America Biogeneric Drugs Sales by Country (2015-2020) (K MT)
Table 69. Latin America Biogeneric Drugs Sales Market Share by Country (2015-2020)
Table 70. Latin Americaa Biogeneric Drugs Revenue by Country (2015-2020) (US$ Million)
Table 71. Latin America Biogeneric Drugs Revenue Market Share by Country (2015-2020)
Table 72. Middle East and Africa Biogeneric Drugs Sales by Country (2015-2020) (K MT)
Table 73. Middle East and Africa Biogeneric Drugs Sales Market Share by Country (2015-2020)
Table 74. Middle East and Africa Biogeneric Drugs Revenue by Country (2015-2020) (US$ Million)
Table 75. Middle East and Africa Biogeneric Drugs Revenue Market Share by Country (2015-2020)
Table 76. Sandoz International Corporation Information
Table 77. Sandoz International Description and Business Overview
Table 78. Sandoz International Biogeneric Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 79. Sandoz International Biogeneric Drugs Product
Table 80. Sandoz International Recent Development
Table 81. Teva pharmaceutical industries Corporation Information
Table 82. Teva pharmaceutical industries Description and Business Overview
Table 83. Teva pharmaceutical industries Biogeneric Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 84. Teva pharmaceutical industries Product
Table 85. Teva pharmaceutical industries Recent Development
Table 86. Mylan Corporation Information
Table 87. Mylan Description and Business Overview
Table 88. Mylan Biogeneric Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 89. Mylan Product
Table 90. Mylan Recent Development
Table 91. 3SBio Corporation Information
Table 92. 3SBio Description and Business Overview
Table 93. 3SBio Biogeneric Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 94. 3SBio Product
Table 95. 3SBio Recent Development
Table 96. Shanghai Fosun Pharmaceutical Corporation Information
Table 97. Shanghai Fosun Pharmaceutical Description and Business Overview
Table 98. Shanghai Fosun Pharmaceutical Biogeneric Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 99. Shanghai Fosun Pharmaceutical Product
Table 100. Shanghai Fosun Pharmaceutical Recent Development
Table 101. Tonghua Dongbao Pharmaceutical Corporation Information
Table 102. Tonghua Dongbao Pharmaceutical Description and Business Overview
Table 103. Tonghua Dongbao Pharmaceutical Biogeneric Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 104. Tonghua Dongbao Pharmaceutical Product
Table 105. Tonghua Dongbao Pharmaceutical Recent Development
Table 106. Biocon Corporation Information
Table 107. Biocon Description and Business Overview
Table 108. Biocon Biogeneric Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 109. Biocon Product
Table 110. Biocon Recent Development
Table 111. Reliance life sciences Corporation Information
Table 112. Reliance life sciences Description and Business Overview
Table 113. Reliance life sciences Biogeneric Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 114. Reliance life sciences Product
Table 115. Reliance life sciences Recent Development
Table 116. Probiomed Corporation Information
Table 117. Probiomed Description and Business Overview
Table 118. Probiomed Biogeneric Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 119. Probiomed Product
Table 120. Probiomed Recent Development
Table 121. Biosidus Corporation Information
Table 122. Biosidus Description and Business Overview
Table 123. Biosidus Biogeneric Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 124. Biosidus Product
Table 125. Biosidus Recent Development
Table 126. AMEGA Biotech Corporation Information
Table 127. AMEGA Biotech Description and Business Overview
Table 128. AMEGA Biotech Biogeneric Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 129. AMEGA Biotech Product
Table 130. AMEGA Biotech Recent Development
Table 131. Celltrion Corporation Information
Table 132. Celltrion Description and Business Overview
Table 133. Celltrion Biogeneric Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 134. Celltrion Product
Table 135. Celltrion Recent Development
Table 136. LG life Science Corporation Information
Table 137. LG life Science Description and Business Overview
Table 138. LG life Science Biogeneric Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 139. LG life Science Product
Table 140. LG life Science Recent Development
Table 141. Dong-A Pharmaceutical Corporation Information
Table 142. Dong-A Pharmaceutical Description and Business Overview
Table 143. Dong-A Pharmaceutical Biogeneric Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 144. Dong-A Pharmaceutical Product
Table 145. Dong-A Pharmaceutical Recent Development
Table 146. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 147. Key Challenges
Table 148. Market Risks
Table 149. Main Points Interviewed from Key Biogeneric Drugs Players
Table 150. Biogeneric Drugs Customers List
Table 151. Biogeneric Drugs Distributors List
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. Biogeneric Drugs Product Picture
Figure 2. Global Biogeneric Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Insulins Product Picture
Figure 4. Growth Hormones Product Picture
Figure 5. Monoclonal Antibodies Product Picture
Figure 6. Others Product Picture
Figure 7. Global Biogeneric Drugs Sales Market Share by Application in 2020 & 2026
Figure 8. Hospital
Figure 9. Clinics
Figure 10. Research Centers
Figure 11. Biogeneric Drugs Report Years Considered
Figure 12. Global Biogeneric Drugs Market Size 2015-2026 (US$ Million)
Figure 13. Global Biogeneric Drugs Sales 2015-2026 (K MT)
Figure 14. Global Biogeneric Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Biogeneric Drugs Sales Market Share by Region (2015-2020)
Figure 16. Global Biogeneric Drugs Sales Market Share by Region in 2019
Figure 17. Global Biogeneric Drugs Revenue Market Share by Region (2015-2020)
Figure 18. Global Biogeneric Drugs Revenue Market Share by Region in 2019
Figure 19. Global Biogeneric Drugs Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Biogeneric Drugs Revenue in 2019
Figure 21. Biogeneric Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Biogeneric Drugs Sales Market Share by Type (2015-2020)
Figure 23. Global Biogeneric Drugs Sales Market Share by Type in 2019
Figure 24. Global Biogeneric Drugs Revenue Market Share by Type (2015-2020)
Figure 25. Global Biogeneric Drugs Revenue Market Share by Type in 2019
Figure 26. Global Biogeneric Drugs Market Share by Price Range (2015-2020)
Figure 27. Global Biogeneric Drugs Sales Market Share by Application (2015-2020)
Figure 28. Global Biogeneric Drugs Sales Market Share by Application in 2019
Figure 29. Global Biogeneric Drugs Revenue Market Share by Application (2015-2020)
Figure 30. Global Biogeneric Drugs Revenue Market Share by Application in 2019
Figure 31. China Biogeneric Drugs Sales Growth Rate 2015-2026 (K MT)
Figure 32. China Biogeneric Drugs Revenue Growth Rate 2015-2026 (US$ Million)
Figure 33. China Biogeneric Drugs Market Share in Global Market 2015-2026
Figure 34. China 5 and 10 Largest Biogeneric Drugs Players Market Share by Revenue in Biogeneric Drugs in 2019
Figure 35. China Biogeneric Drugs Revenue Share by Type (2015-2020)
Figure 36. China Biogeneric Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 37. China Biogeneric Drugs Revenue Share by Application (2015-2020)
Figure 38. China Biogeneric Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 39. North America Biogeneric Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 40. North America Biogeneric Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. North America Biogeneric Drugs Sales Market Share by Country in 2019
Figure 42. North America Biogeneric Drugs Revenue Market Share by Country in 2019
Figure 43. U.S. Biogeneric Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 44. U.S. Biogeneric Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. Canada Biogeneric Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 46. Canada Biogeneric Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. Europe Biogeneric Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 48. Europe Biogeneric Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 49. Europe Biogeneric Drugs Sales Market Share by Country in 2019
Figure 50. Europe Biogeneric Drugs Revenue Market Share by Country in 2019
Figure 51. Germany Biogeneric Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 52. Germany Biogeneric Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. France Biogeneric Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 54. France Biogeneric Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. U.K. Biogeneric Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 56. U.K. Biogeneric Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Italy Biogeneric Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 58. Italy Biogeneric Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Russia Biogeneric Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 60. Russia Biogeneric Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Asia Pacific Biogeneric Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 62. Asia Pacific Biogeneric Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 63. Asia Pacific Biogeneric Drugs Sales Market Share by Region in 2019
Figure 64. Asia Pacific Biogeneric Drugs Revenue Market Share by Region in 2019
Figure 65. China Biogeneric Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 66. China Biogeneric Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Japan Biogeneric Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 68. Japan Biogeneric Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. South Korea Biogeneric Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 70. South Korea Biogeneric Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. India Biogeneric Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 72. India Biogeneric Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Australia Biogeneric Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 74. Australia Biogeneric Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Taiwan Biogeneric Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 76. Taiwan Biogeneric Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Indonesia Biogeneric Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 78. Indonesia Biogeneric Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Thailand Biogeneric Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 80. Thailand Biogeneric Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Malaysia Biogeneric Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 82. Malaysia Biogeneric Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Philippines Biogeneric Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 84. Philippines Biogeneric Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Vietnam Biogeneric Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 86. Vietnam Biogeneric Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 87. Latin America Biogeneric Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 88. Latin America Biogeneric Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America Biogeneric Drugs Sales Market Share by Country in 2019
Figure 90. Latin America Biogeneric Drugs Revenue Market Share by Country in 2019
Figure 91. Mexico Biogeneric Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 92. Mexico Biogeneric Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil Biogeneric Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 94. Brazil Biogeneric Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina Biogeneric Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 96. Argentina Biogeneric Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Middle East and Africa Biogeneric Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 98. Middle East and Africa Biogeneric Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Biogeneric Drugs Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Biogeneric Drugs Revenue Market Share by Country in 2019
Figure 101. Turkey Biogeneric Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 102. Turkey Biogeneric Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Biogeneric Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 104. Saudi Arabia Biogeneric Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Biogeneric Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 106. U.A.E Biogeneric Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Porter's Five Forces Analysis
Figure 108. Biogeneric Drugs Value Chain
Figure 109. Channels of Distribution
Figure 110. Distributors Profiles
Figure 111. Bottom-up and Top-down Approaches for This Report
Figure 112. Data Triangulation
Figure 113. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs